Lucid Diagnostics Inc. (LUCD)
USD 1.5
(-0.33%)
USD 1.5
(-0.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.42 Million USD | 544.03% |
| 2022 | 377 Thousand USD | -24.6% |
| 2021 | 500 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 976 Thousand USD | -2.5% |
| 2024 Q1 | 1 Million USD | -3.75% |
| 2023 Q3 | 783 Thousand USD | 392.45% |
| 2023 Q4 | 1.04 Million USD | 32.82% |
| 2023 FY | 2.42 Million USD | 544.03% |
| 2023 Q1 | 446 Thousand USD | 298.21% |
| 2023 Q2 | 159 Thousand USD | -64.35% |
| 2022 Q3 | 76 Thousand USD | 0.0% |
| 2022 Q2 | - USD | -100.0% |
| 2022 FY | 377 Thousand USD | -24.6% |
| 2022 Q1 | 189 Thousand USD | -37.0% |
| 2022 Q4 | 112 Thousand USD | 47.37% |
| 2021 Q2 | - USD | 0.0% |
| 2021 FY | 500 Thousand USD | 0.0% |
| 2021 Q4 | 300 Thousand USD | 50.0% |
| 2021 Q3 | 200 Thousand USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 79.866% |
| BrainsWay Ltd. | 31.78 Million USD | 92.361% |
| Cerus Corporation | 156.36 Million USD | 98.447% |
| Envoy Medical, Inc. | 316 Thousand USD | -668.354% |
| electroCore, Inc. | 16.03 Million USD | 84.853% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -277.019% |
| IceCure Medical Ltd | 3.22 Million USD | 24.806% |
| Inogen, Inc. | 315.66 Million USD | 99.231% |
| OrthoPediatrics Corp. | 148.73 Million USD | 98.368% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -565.207% |
| MaxCyte, Inc. | 41.28 Million USD | 94.119% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -24.357% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2092.365% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.675% |
| PAVmed Inc | 2.45 Million USD | 0.979% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 89.218% |
| RxSight, Inc. | 89.07 Million USD | 97.274% |
| Sight Sciences, Inc. | 81.05 Million USD | 97.005% |
| SI-BONE, Inc. | 138.88 Million USD | 98.252% |
| TELA Bio, Inc. | 58.45 Million USD | 95.846% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 98.702% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 82.407% |
| Acutus Medical, Inc. | 7.16 Million USD | 66.108% |
| Talis Biomedical Corporation | 412 Thousand USD | -489.32% |
| Spectral AI, Inc. | 18.05 Million USD | 86.553% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 75.487% |
| CVRx, Inc. | 39.29 Million USD | 93.821% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -150.644% |
| Bioventus Inc. | 512.34 Million USD | 99.526% |
| Venus Concept Inc. | 76.35 Million USD | 96.82% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 86.883% |
| LivaNova PLC | 1.15 Billion USD | 99.79% |
| 908 Devices Inc. | 50.22 Million USD | 95.166% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.497% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -3051.446% |
| NeuroPace, Inc. | 65.42 Million USD | 96.289% |
| LENSAR, Inc. | 42.16 Million USD | 94.242% |
| Apyx Medical Corporation | 52.34 Million USD | 95.362% |
| Cutera, Inc. | 212.36 Million USD | 98.857% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 92.721% |
| BioSig Technologies, Inc. | 18 Thousand USD | -13388.889% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 98.543% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 89.864% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.842% |
| Axonics, Inc. | 366.37 Million USD | 99.337% |
| Outset Medical, Inc. | 130.37 Million USD | 98.138% |
| IRIDEX Corporation | 51.86 Million USD | 95.319% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 98.217% |
| IRadimed Corporation | 65.56 Million USD | 96.297% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -106.463% |
| INVO Bioscience, Inc. | 3.02 Million USD | 19.618% |
| Telesis Bio, Inc. | 27.5 Million USD | 91.174% |
| Viemed Healthcare, Inc. | 183 Million USD | 98.673% |
| Varex Imaging Corporation | 811 Million USD | 99.701% |
| Quipt Home Medical Corp. | 221.74 Million USD | 98.905% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 96.465% |
| Dynatronics Corporation | 32.53 Million USD | 92.537% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 72.021% |
| Semler Scientific, Inc. | 68.18 Million USD | 96.439% |
| InMode Ltd. | 492.04 Million USD | 99.507% |
| Bruker Corporation | 2.96 Billion USD | 99.918% |
| Cytosorbents Corporation | 36.34 Million USD | 93.32% |
| DexCom, Inc. | 3.62 Billion USD | 99.933% |
| Align Technology, Inc. | 3.86 Billion USD | 99.937% |
| Viveve Medical, Inc. | 6.42 Million USD | 62.216% |
| ZimVie Inc. | 457.43 Million USD | 99.469% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 98.742% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2092.365% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.675% |
| Profound Medical Corp. | 7.33 Million USD | 66.88% |
| Insulet Corporation | 1.69 Billion USD | 99.857% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 98.074% |
| iCAD, Inc. | 17.31 Million USD | 85.98% |
| Nuwellis, Inc. | 8.86 Million USD | 72.608% |
| Biotricity, Inc. | 12.06 Million USD | 79.873% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.507% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 60.87% |
| PAVmed Inc. | 2.45 Million USD | 0.979% |
| BIOLASE, Inc. | 49.16 Million USD | 95.061% |
| Beyond Air, Inc. | 1.15 Million USD | -109.491% |
| FONAR Corporation | 102.88 Million USD | 97.64% |
| AxoGen, Inc. | 159.01 Million USD | 98.473% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.115% |
| Inari Medical, Inc. | 493.63 Million USD | 99.508% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.393% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -12953.763% |
| Tenon Medical, Inc. | 2.92 Million USD | 17.077% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 64.357% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.924% |
| Sintx Technologies, Inc. | 2.62 Million USD | 7.575% |
| NanoVibronix, Inc. | 2.28 Million USD | -6.351% |
| Quanterix Corporation | 122.36 Million USD | 98.016% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 90.051% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 98.789% |
| TransMedics Group, Inc. | 241.62 Million USD | 98.995% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 82.474% |
| NeuroMetrix, Inc. | 5.9 Million USD | 58.857% |
| Hyperfine, Inc. | 11.03 Million USD | 77.991% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 98.53% |
| Biomerica, Inc. | 5.41 Million USD | 55.162% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 95.198% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 98.629% |